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Ruta graveolens (the common rue) has been used for various therapeutic purposes, including
relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on
main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and
its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-
glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate)
(NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration
of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent
manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and
Cyp2b activities and protein levels in males and females. This treatment increased hepatic
UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidore-
ductase activity remained unchanged. Based on the contents of rutin and furanocoumarinsChinese Medicine,
icine, 155-1, Li-Nong
. Ueng).
ministration, Taiwan. Published by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8 517rutinUDP-glucuronosyltransferaseof mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of
furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix
increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed
at least in part to the P450 induction by rue.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
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Fig. 1 e Structures of rutin and furanocoumarins identified
in the rue aqueous extract. MOP ¼ methoxypsoralen.1. Introduction
Drug-metabolizing enzymes play a crucial role in the
biotransformation of xenobiotics, including drugs and chemi-
cal carcinogens, as well as physiological substances such as
steroids. In Phase I metabolism, microsomal cytochrome P450
(P450/CYP)-dependent monooxygenase is the primary enzyme
system that is responsible for oxidations. Thismonooxygenase
system participates in the oxidation of a variety of endogenous
and exogenous substrates, such as testosterone, methadone,
and codeine [1]. P450 catalyzes theoxidations by transfer of two
electrons through NADPHeP450 reductase (CPR), and the sec-
ondelectroncanalsobe transferredbycytochromeb5. Enzymes
of the P450 superfamily exhibit broad substrate specificity and
functional diversity. Therefore, selective substrates have been
used as chemical probes for characterizing functional changes
in individual P450 isoforms [1]. In the nomenclature of P450
isoforms, lowercase letters are used only for mouse P450, such
as Cyp1a2 (http://drnelson.uthsc.edu/cytochromeP450.html).
In Phase II metabolic reactions, uridine diphosphate (UDP)-
glucuronosyltransferase (UGT)-catalyzed glucuronidation is
quantitatively the most important conjugative reaction and
appears to be themainmetabolic pathway of a variety of drugs,
such as acetaminophen. Reduced nicotinamide adenine dinu-
cleotide (phosphate) (NAD(P)H):quinone oxidoreductase (NQO)
catalyzes further oxidationofquinone substrates, including the
antineoplastic agent mitomycin C [2]. Functions of drug-
metabolizing enzymes can be modulated by several natural
products, such as psoralen derivatives [3e5]. Alterations of
drug-metabolizing enzymes may result not only in herbedrug
interaction, but also in changes in physiological functions of
endogenous substrates or in carcinogenicity of xenobiotics.
Ruta graveolens L. (Yuin Siang), commonly known as rue, has
been used in America, Asia, and Europe for the treatment of
heart disease, wounds, and rheumatism [6,7]. In Taiwan, the
aerial part of rue has been reputedly used as a folkmedicine for
the treatment of circulatory disorders. In Europe, this plant has
also been used as an abortifacient and emmenagogue [6].
Aqueous extract of rue was found to reduce human sperm
motility [8].According to the53-dayspermatogenic cycle in rats,
a study of 60-day treatment of rue was designed and the
changes in the rue-treated groupwere compared to those in the
vehicle control group [9]. Oral administration of rue aqueous
extract at 0.5 g/kg/d to male adult rats for 60 days decreased
their serum testosterone level, suppressed spermmotility and
number ofmounts, andprolongedejaculatory latency. Types of
chemical compounds identified in rue include coumarins, fla-
vonoids, lignans, and quinoline alkaloids [10]. Furanocoumar-
ins, such as 8-methoxypsoralen (MOP) and chalepensin (Fig. 1),
represent one group of biologically active rue constituents andcan be linked to the phototoxicity and antifertility of rue [10].
The flavonoid rutin (Fig. 1) has been identified as a water-
soluble glycoside in rue [11]. In the evaluation of the utero-
tonic activities of rue fractionations, rutin was found in the
active fraction and had themost potent uterotonic effect [11]. It
has been suggested that furanocoumarins and rutin play
important roles in the pharmacological/toxicological effects of
rue.
In the modulation of drug-metabolizing enzymes, intra-
peritoneal administration of a single dose of 25 mg/kg 8-MOP
to rats induced hepatic CYP2B after 24 hours and 48 hours [3].
Chalepensin activated the mouse constitutive androstane
receptor (CAR) and induced Cyp2b9/10 in male C57BL/6JNarl
mice after 1 week of treatment [4]. By contrast, some of the
furanocoumarins in rue, such as 5-MOP, 8-MOP, and chale-
pensin, are known potent mechanism-based inhibitors of
CYP2A and CYP3A in vitro and/or in vivo [5,12]. Rutin is catab-
olized by human intestinal/fecal bacteria to form deglycosy-
lated products including leucocyanidin and quercetin [13].
Quercetin induced CYP1A1 expression in HepG2 cells,
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8518whereas rutin did not [14]. To a lesser extent, quercetin
elevated the UGT mRNA level. These reports indicated that
rutin and furanocoumarins may affect drug-metabolizing
enzymes. However, the effect of rue remained unclear. In
this study, to elucidate the effects of rue on hepatic and renal
drug-metabolizing enzymes, an aqueous extract of rue was
prepared and the contents of rutin and furanocoumarins in
the extract were determined. The effects of oral administra-
tion of rue on P450 isoforms, UGT, and NQO were studied.
Based on the contents of the rue extract, the effects of rutin
and the mixture of furanocoumarins (Fmix) were studied to
reveal their contribution to the enzyme induction by rue.2. Materials and methods
2.1. Chemicals and antibodies
Coumarin, dextromethorphan, dextrophan, glucose-6-
phosphate, glucose-6-phosphate dehydrogenase, nicotina
mide adenine dinucleotide phosphate (NADPþ), 7-
ethoxyresorufin, 7-methoxyresorufin, 7-pentoxyresorufin, 5-
MOP, 8-MOP, nifedipine, psoralen, and rutin were purchased
from Sigma-Aldrich Co. (St Louis, MO, USA). Rutin was further
purified by column chromatography using Sephadex LH-20
and the purity was 98% [high-performance liquid chromatog-
raphy (HPLC) analysis]. Chalepensin was isolated and purified
from the ethanolic extract of rue with a purity of 99% (HPLC
analysis), as described previously [12]. The oxidation product
[2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid
dimethyl ester] of nifedipine was generously provided by Dr F.
Peter Guengerich (Nashville, TN, USA). Acrylamide, N,N0-
methylene-bis-acrylamide and sodium dodecyl sulfate for
immunoblot analyses were purchased from Bio-Rad Labora-
tories (Hercules, CA, USA). Acetonitrile and methanol were
purchased from Merck KGaA (Darmstadt, Germany). Mono-
clonal antibody Mab1-7-1 against rat CYP1A was generously
provided by Dr S.S. Park (Seoul, Korea) [15]. Rabbit polyclonal
antibody against rat CYP2B1, which was immunoreacted with
mouse Cyp2b, was purchased from NOSAN Co. (Yokohama,
Japan) [16]. Rabbit polyclonal antibody against rat CPR was
prepared following the method of Kaminsky et al [17]. Rabbit
polyclonal antibodies against human UGT1A, which was
immunoreacted with mouse UGT in the liver lysate shown in
the datasheet (Cat. No. GTX114131), was purchased from
GeneTex Intl Co. (Hsinchu City, Taiwan). Horseradish
peroxidase-conjugated rabbit antimouse IgG and goat anti-
rabbit IgG were purchased from Thermo Scientific Pierce Pro-
tein Research Products (Rockford, IL, USA).
2.2. Preparation and HPLC analysis of rue aqueous
extract
The fresh aerial part of R. graveolens (rue) was purchased from
the herb market in Taipei, and the species was authenticated
by Dr I.-J. Lee. Rue (2.46 kg) was blended in 7 L of deionized
water and then 3.5 L of water was added to it. After heating at
95C for 1 hour, the herbal decoction was cooled to room
temperature and filtered using a steel sieve. The filtrate was
centrifuged at 9000g for 40 minutes at 4C. The supernatantwas collected, filtered through a filter paper (ADVANTEC; Toyo
Roshi Kaisha, Ltd, Tokyo, Japan) and lyophilized. A total of
20.54 g of extract was obtained from 1 kg of rue. To determine
the rutin and furanocoumarin contents, rue aqueous extract
(100 mg) was extracted twice using 2 mL of methanol. After
centrifugation and filtration through a 0.45-mm filter, the
filtrate was subjected to HPLC analysis. An Agilent 1100 HPLC
system (Agilent Technology, Santa Clara, CA, USA) equipped
with a photodiode array detector and a C18 column (Cosmosil
5C18-AR-II, 4.6 250mm2, 5 mm;Nacalai Tesque, Kyoto, Japan)
was used. Ingredients of the rue extract were separated using
acetonitrile/methanol (1:1) (A) and 10% methanol (B), with
stepwise changes of linear gradients: 0 minute, 100% B; 45
minutes, 50% A and 50% B; 50 minutes, 50% A and 50% B; 60
minutes, 100% A; 62 minutes, 100% B; 70 minutes, 100% B.
Rutin and furanocoumarins were detected by measuring the
absorbance at 246 nm. In addition to the retention time and
absorbance spectrum, the presence of furanocoumarins was
further confirmed by an analysis of rue extract spiked with
individual standards (chromatogram not shown). Purified or
commercially available compounds were used as the stan-
dards for quantification.
2.3. Animal treatments and determination of serum
biochemical parameters
C57BL/6JNarl mice (5-week old, weighing 17e20 g) were pur-
chased from the National Laboratory Animal Center (Taipei,
Taiwan). All experimental protocols involving animals were
reviewed and approved by the Institutional Animal Care and
Use Committee of the National Research Institute of Chinese
Medicine (IACUC 100-10, approved on December 22, 2011).
Prior to experimentation, mice were allowed an 1-week
acclimation period at the climate-controlled animal quarters
with free access to laboratory rodent chow (No. 5P14; PMI
Feeds Inc., Richmond, IN, USA) and water. The known Cyp1a
and Cyp2b inducers are, respectively, 3-methylcholanthrene
(3-MC) and phenobarbital (PB). Mice in the Cyp1a and Cyp2b
induction positive control groups were treated by intraperi-
toneal injection of 3-MC (a single injection of 80 mg/kg and
microsomes were prepared after 2 days) and PB (80 mg/kg
daily for 4 days), respectively. Rue extract was ground using a
mortar and pestle, and suspended in deionized water using a
set of Teflon pestle-glass homogenizers. The suspension was
mixed by vortexing before administration to each mouse by
oral gavage. The control group received the same amount of
water only. Based on the contents of rutin and fur-
anocoumarins in the rue extract, 1.2 mg/mL rutin and Fmix (a
mixture of 0.13 mg/mL psoralen, 5 mg/mL 8-MOP, 0.14 mg/mL
5-MOP, and 5 mg/mL chalepensin) were dissolved in corn oil in
brown vials. Micewere treatedwith rutin and Fmix at 0.01mL/g
body weight through oral gavage for 7 days. The control group
received the same amount of corn oil. Mice were euthanized
by CO2 asphyxiation 22 hours after the last treatment. Prior to
asphyxiation, the mice were anesthetized using ether (in a
chemical safety hood); bloodwas collected frommice by heart
puncture, and the sera were separated by centrifugation at
9600g for 10 minutes at 4C. Serum aspartate aminotrans-
ferase and alanine aminotransferase activities, and blood urea
nitrogen and creatinine levels were determined using analysis
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8 519kits designed for a Fujifilm Dri-Chem 3000 colorimetric
analyzer (Fujifilm, Saitama, Japan).
2.4. Microsomal and cytosolic preparations, and enzyme
assays
Microsomal and cytosolic fractions of liver and kidney tissues
were prepared by differential centrifugation at 4C [4]. Liver
microsomal pellets were further resuspended using 1.15% KCl
and centrifuged again at 100,000g for 1 hour at 4C to prepare
washed microsomes. The washed liver microsomes, kidney200
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Fig. 2 e (A) Chromatograms and (B) spectra of peaks in HPLC ana
Ruta graveolens (rue) extract. A standard furanocoumarin mixtur
MOP (0.54 mg), and psoralen (0.47 mg) were prepared in methan
methanol and subjected to HPLC analysis. Rue extract was mix
subjected to HPLC analysis. The spectra of peaks appearing in
shown. HPLC ¼ high-performance liquid chromatography; MOPmicrosomes, and cytosols of kidney and liver samples were
used for enzyme assays. Microsomal contents of P450 and
cytochrome b5 were determined using spectrophotometric
methods [18]. Cytochrome c was used as a substrate to
determine CPR activity, as described by Phillips and Langdon
[19]. Activities of 7-ethoxyresorufin O-deethylation (EROD), 7-
methoxyresorufin O-demethylation (MROD), and 7-
pentoxyresorufin O-dealkylation (PROD) were determined by
measuring the fluorescence of resorufin [20,21]. Activities of
dextromethorphan O-demethylation and coumarin 7-
hydroxylation were determined by HPLC with a fluorescence400 200 400
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ed vigorously in methanol, and 15 ml of the filtrate was
the chromatogram of standards and the rue extract are
¼ methoxypsoralen.
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tivity was determined by measuring formaldehyde formation
using Nash's reagent [24]. Nifedipine oxidation activity was
determined by HPLC with a UV detector [25]. Microsomal UGT
and cytosolic NQO activities were determined using p-nitro-
phenol and menadione as substrates, respectively [26,27].
Protein concentrations were determined using bovine serum
albumin as a standard for establishing the linear relationship
between protein concentration and absorbance, as described
by Lowry et al [28].2.5. Immunoblot analyses
Microsomal proteins (12e50 mg) were resolved by electropho-
resis on a 7.5% (for UGT) or 10% (for P450) (w/v) polyacrylamideDays
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resis, 14  20  0.15 cm3) and electrotransferred from the slab
gel to a nitrocellulose membrane, as described previously [4].
Immunoblot analysis of microsomal Cyp1a1/2 was performed
using Mab 1-7-1 [15]. Immunoblot analyses of microsomal
Cyp2b9/10 and CPR were performed using rabbit polyclonal
antibodies against rat CYP2B1 and CPR, respectively. Cytosolic
proteins (20 mg) were resolved by electrophoresis on a 12% (w/
v) polyacrylamide gel. Immunoreactive proteins were detec-
ted using a goat antirabbit IgG conjugated with horseradish
peroxidase and visualized using an enhanced chem-
iluminescence detection kit (PerkinElmer Life and Analytical
Sciences, Inc., Shelton, CA, USA). Relative band intensity was
analyzed with the Multi Gauge software (version 2.2; Fujifilm
Co., Tokyo, Japan).Days
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j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8 5212.6. Data analyses
The differences in the experiments withmore than two sets of
data from mice treated with different doses of rue extract
were analyzed by one-way analysis of variance, followed by
Dunnett's test for multiple comparisons (SigmaStat version
2.03; SPSS Inc., Chicago, IL, USA). Statistical significance of the
difference between the control and individual treatment
groups was evaluated with Student t test. A p value <0.05 was
considered statistically significant.Table 1 e Effects of R. graveolens extract on hepatic content an
monooxygenase components in male and female mice.
Monooxygenase component Control
Cytochrome P450 (nmol/mg protein) 0.64 ± 0.05
Cytochrome b5 (nmol/mg protein) 0.30 ± 0.03
NADPH-P450reductase (nmol/min/mg protein) 189 ± 23
Mice were treated with water or 0.5 g rue extract/kg/d for 7 days. The co
mean ± standard error of the mean of seven male and eight female mice3. Results
3.1. Quantitation of rutin and the furanocoumarins in
the aqueous extract of the aerial part of rue
The chromatogram in Fig. 2A shows the absorbance of stan-
dards and rue extract at 246 nm under the HPLC conditions
described in the Materials and method section. The retention
time (Fig. 2A) and absorbance spectra (Fig. 2B) of the peaks in
the chromatogram indicated that the identified peaks wered reduction activity of cytochrome P450-dependent
Male Female
Rue extract Control Rue extract
0.63 ± 0.05 0.41 ± 0.02 0.41 ± 0.01
0.34 ± 0.03 0.39 ± 0.02 0.43 ± 0.01
168 ± 16 246 ± 7 249 ± 6
ntrol group received the same volume of water. Data represent the
.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8522rutin (1), psoralen (2), 8-MOP (3), 5-MOP (4), and chalepensin
(5). There were 23.7 ± 0.3 mg rutin, 2.6 ± 0.1 mg psoralen,
81 ± 6 mg 8-MOP, 2.7 ± 0.1mg 5-MOP, and 87 ± 1 mg chalepensin
(mean ± SE of triple determinations) in 1 g of rue extract.
3.2. Dose and time dependence of rue extract-mediated
induction of Cyp1a and Cyp2b
To determine the doseeresponse of the effects of rue extract
on P450s, male mice were treated with rue extract at a daily
dose of 0.05e2 g/kg for 7 days. In the determination of liver
microsomal activities toward CYP1A substrate 7-Fig. 5 e (A) Effects of rue extract on hepatic marker activities of c
in male and female mice. Mice were treated with 0.5 g extract/kg
of water. Data represent the mean ± standard error of the mean
with the control group. NQO ¼ NAD(P)H:quinone oxidoreductasethoxyresorufin, treatment of mice with rue extract at a
dose lower than 0.25 g/kg did not affect liver microsomal
EROD activity (Fig. 3A, left panel). Treatment with 0.5 g/kg,
1 g/kg, and 2 g/kg extract significantly increased EROD activity
by 17%, 23%, and 27%, respectively. In the determination of
P450 activity toward CYP2B substrate 7-pentoxyresorufin, rue
extract at a dose lower than 0.1 g/kg could not affect liver
microsomal PROD activity (Fig. 3A, right panel). Rue extract at
0.25e2 g/kg significantly increased PROD by 59e102%. Thus,
male mice were treated with 0.5 g/kg rue extract for 3 days
and 7 days to examine the time dependence of P450
induction.ytochrome P450 isoforms and (B) activities of UGT and NQO
/d for 7 days. The control group received the same amount
of seven male and eight female mice. *p < 0.05, compared
e; UGT ¼ UDP-glucuronosyltransferase.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8 523The 3-day treatment did not affect hepatic EROD and PROD
activities (Fig. 3B). However, rue extract increased EROD and
PROD activities by 18% and 61%, respectively, after 7 consec-
utive days. To examine the effects of rue on the activities of
other P450s and Phase II enzymes,male and femalemicewere
treated with 0.5 g/kg rue extract for 7 days in the following
studies. Treatment ofmicewith a prototype CYP1A inducer, 3-
MC, caused a 15-fold increase in liver microsomal EROD ac-
tivity. PB, a potent CYP2B inducer, caused an 11-fold increase
of PROD activity. Microsomes of 3-MC- and PB-treated mice
were used as markers for the immunoblot analyses of
microsomal Cyp1a and Cyp2b.
3.3. Effects of rue extract on hepatic P450, UGT, and
NQO activities in male and female mice
Mouse body and tissue weights were not significantly affected
after a 1-week treatment with 0.5 g/kg rue extract (Fig. 4A).
This treatment did not elevate male and female mouse serum
alanine aminotransferase and aspartate aminotransferase
levels (Fig. 4B). Treatment of male mice with 0.5 g/kg/d rue
extract for 1 week did not affect liver microsomal P450 and
cytochrome b5 contents, and CPR activity (Table 1). This rue
treatment caused 27%, 47%, and 80% increases of hepatic
EROD (CYP1A), MROD (CYP1A), and PROD (CYP2B) activities,N
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group received the same amount of water. Data represent the m
male and eight female mice, in which tissues of two mice were
oxidoreductase; UGT ¼ UDP-glucuronosyltransferase.respectively (Fig. 5A). However, under this treatment regimen,
rue extract could not affect hepatic coumarin 7-
hydroxylation, dextromethorphan O-demethylation, nitro-
sodimethylamine N-demethylation, and nifedipine oxidation
activities, which were the marker activities of CYP2A, CYP2D,
CYP2E1, and CYP3A, respectively. Microsomal UGT activity
was induced by 45% (Fig. 5B), whereas rue extract did not
affect cytosolic NQO activity. At a dose lower than 0.1 g/kg, rue
extract did not affect UGT activity (data not shown).
In female mice, 7-day treatment with 0.5 g/kg rue extract
did not affect liver microsomal P450 and cytochrome b5 con-
tents and CPR activity (Table 1). Microsomal EROD, MROD, and
PROD activities were increased by 31%, 59%, and 47%,
respectively (Fig. 5A). Hepatic marker activities of CYP2A,
CYP2D, CYP2E1, and CYP3A were not affected by this treat-
ment regimen. The activities of liver microsomal UGT and
cytosolic NQO remained unchanged (Fig. 5B).
3.4. Effects of rue extract on renal P450, UGT, and NQO
activities in male and female mice
With the exception of renal cytosolic NQO activity being
higher than hepatic activity, renal P450 and UGT activities
were lower than hepatic activities (Figs. 5 and 6). Rue did not
change kidney microsomal P450 content and CPR activity in
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Fig. 7 e Immunoblot analyses of liver microsomal Cyp1a1/
2, Cyp2b9/10, CPR, and UGT in control and rue extract-
treated mice: (A) representative blots and (B) relative band
intensity compared to that of control mice. Male and
female mice were treated with a daily dose of 0.5 g/kg rue
extract for 7 days. Microsomes of mice treated with
inducers 3-MC and PB were loaded as markers for Cyp1a1/
2 and Cyp2b9/10, respectively. For the analysis of Cyp1a
enzymes, microsomal proteins of control (50 mg/well), rue-
treated (50 mg/well), and 3-MC-treated (25 mg/well) mice
were loaded on a polyacrylamide gel. For the analysis of
Cyp2b, microsomal proteins of control (30 mg/well), rue-
treated (30 mg/well), and PB-treated (12 mg/well) mice were
loaded. In each well, 30 mg and 50 mg microsomal proteins
were loaded for the analyses of CPR and UGT levels,
respectively. Data of band intensity represent the
mean ± standard error of the mean of three mice. *p < 0.05,
compared with the control group. a Unidentified protein
band. CPR ¼ NADPHecytochrome P450 reductase; 3-
MC ¼ 3-methylcholanthrene; PB ¼ phenobarbital;
UGT ¼ UDP-glucuronosyltransferase.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8524male and femalemice (Fig. 6A). Due to the elevation of hepatic
Cyp1a and Cyp2b activities by rue, kidney microsomal P450
activities toward 7-ethoxyresorufin and 7-pentoxyresorufin
were determined. In contrast to the inductive response in
the liver, 7-day treatment with 0.5 g/kg rue extract did not
affect the renal EROD and PROD activities. Under this treat-
ment regimen, kidney microsomal coumarin 7-hydroxylation
activity was not altered by rue extract (Fig. 6A). The rue extract
did not affect renal UGT and NQO activities either (Fig. 6B).
3.5. Elevation of liver microsomal Cyp1a, Cyp2b9/10,
and UGT proteins by rue extract
Since rue extract at 0.5 g/kg induced hepatic Cyp1a and Cyp2b
activities in male and female mice, protein levels of Cyp1a1/2,
Cyp2b9/10, and CPRwere determined by immunoblot analysis
(Fig. 7). Consistent with the unchanged activity of CPR, there
was no significant difference in the protein levels of micro-
somal CPR in control and rue extract-treated mice. Cyp1a2
was the primary CYP1A member in the mouse liver [1] and
was detected in the blot of liver microsomes of the control
group (Fig. 7A). Treatment with 3-MC increased the mouse
Cyp1a2 protein level and strongly induced the Cyp1a1 protein
with an apparent molecular weight greater than that of
Cyp1a2 [1]. Therefore, 3-MC-treated mouse liver microsomes
were used as a positive control for Cyp1a1 and Cyp1a2 in-
duction (Fig. 7A). Due to the potent induction of Cyp1a1/2 by 3-
MC, the luminescence-visualized bands of Cyp1a1- and
Cyp1a2-immunoreacted proteins were very close in the blot.
An unidentified protein band with an apparent molecular
weight lower than that of Cyp1a2 was immunodetected in the
3-MC-treated, but not in the vehicle- and rue-treated mouse
liver microsomes. The results of intensity scanning showed
that rue treatment resulted in a 34% and 24% increase in the
Cyp1a2 protein level in male and female mice, respectively
(Fig. 7B). This rue treatment did not elevate Cyp1a1 expression
to a detectable level. PB-treatedmouse liver microsomes were
used as markers of Cyp2b9 and Cyp2b10 induction. Immuno-
blot analysis with an antirat CYP2B1 antibody, which cross-
reacts with mouse Cyp2b9 and Cyp2b10, showed that rue
extract increased the Cyp2b10 protein levels by 155% and 70%
in male and female mice, respectively. Similarly, rue extract
increased Cyp2b9 protein levels by 83% and 52% in male and
female mice, respectively. However, the blot of male mouse
liver microsomes showed some light immunoreacted bands
with mobility between Cyp2b10 and Cyp2b9; these were
mainly and markedly induced by PB (Fig. 7A). Rue extract
increased the UGT1a protein level by 79% in males, but not in
females.
3.6. Effects of rutin and Fmix on hepatic P450, UGT, and
NQO activities
Based on the contents of furanocoumarins in rue extract, the
administration of 0.5 g/kg rue extract resulted in a concurrent
exposure to 12 mg/kg rutin, 1.3 mg/kg psoralen, 0.05 mg/kg 8-
MOP, 1.4 mg/kg 5-MOP, and 0.05 mg/kg chalepensin. Due to its
solubility, corn oil was used as a vehicle. There were no sig-
nificant differences in activities between the water and corn-
oil control groups. To examine the contribution of rutin andfuranocoumarins to the enzyme induction by rue extract,
male mice were treated with rutin, Fmix, and the mixture of
rutin and Fmix for 7 days. Oral administration of rutin in mice
increased liver microsomal EROD and MROD activities by 35%
and 29%, respectively (Fig. 8A). However, rutin treatment had
no effect on PROD activity. Fmix treatment increased PROD
activity by 30%. Treatment with the mixture of rutin and Fmix
resulted in 29%, 35%, and 45% increases of EROD, MROD, and
PROD activities, respectively (Fig. 8A). However, microsomal
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Fig. 8 e (A) Effects of rutin and Fmix on hepatic activities of cytochrome P450 isoforms and (B) activities of UGT and NQO in
male mice. Mice were treated with rutin (12 mg/kg), Fmix (0.05 mg/kg chalepensin, 1.4 mg/kg 5-MOP, 0.05 mg/kg 8-MOP, and
1.3 mg/kg psoralen), and the mixture of rutin and Fmix daily for 1 week. Control group received the same amount of corn oil.
Data represent the mean ± standard error of the mean of five mice. *p < 0.05, compared with the control group.
Fmix ¼ furanocoumarin mixture; MOP ¼ methoxypsoralen; NQO ¼ NAD(P)H:quinone oxidoreductase; UGT ¼ UDP-
glucuronosyltransferase.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8 525activities toward P450 substrates, coumarin (7-hydroxylation),
dextromethorphan, nifedipine, and nitrosodimethylamine
were not affected by rutin and Fmix (results not shown). These
treatments did not affect microsomal UGT and cytosolic NQO
activities (Fig. 8B).4. Discussion
Our findings revealed that rue extract at 0.5 g/kg significantly
elevated hepatic Cyp1a and Cyp2b protein levels and activities
in both male and female mice, whereas activities toward the
marker substrates of CYP2A, CYP2E1, CYP2D, and CYP3A
remained the same. Induction of Cyp1a and Cyp2b occurredafter 7-day treatment, but not after 3-day treatment. This re-
veals that the induction requires a lag-time period, whichmay
be attributed to the time-consuming processes including ab-
sorption, tissue accumulation, receptor activation, andprotein
synthesis. The unchanged activity and protein level of CPR
indicate that the increases in Cyp1a and Cyp2b activities were
not due to the induction of CPR. The induction of mouse
Cyp1a2 and Cyp2b9/10 by rue extract was mild to moderate in
comparison with the potent inducers 3-MC and PB. Under this
treatment regimen, rue-mediated increases in UGT activity
were seen in males but not in females. The increase of UGT
activity was consistent with the elevated protein levels. The
actual cause of the predominantly male induction of UGT by
rue needs further investigation. However, a high-fat diet
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 5 1 6e5 2 8526significantly induced UGT1A1/6 in male rats, but not in fe-
males [29]. Nuclear levels of the CAR and peroxisome
proliferator-activated receptor a were stimulated only in
males. The elevated CAR and peroxisome proliferator-
activated receptor a levels were suggested to be involved in
the male-predominant UGT induction. Testosterone can be
metabolized by glucuronide conjugation and P450-mediated
hydroxylations, in which CYP2B is one of the key isoforms
[30]. Epileptic patients taking a typical CYP2B inducer, PB, had
a reduced level of free testosterone [31]. It was suggested that
P450 induction was one of the potential factors of sexual
dysfunction. It is of interest to clarify the contribution of
CYP2b and UGT induction in the rue-mediated reduction of
testosterone and sexual behavior in experimental animals [9]
and sperm motility in humans [8]. CYP2B and UGT are also
important enzymes for the metabolism of drugs, such as
methadone [32]. Alterations of CYP2B andUGT function can be
associated with the methadone dose and the incidence of
withdrawal symptoms. Thepotential interactionof rue extract
and CYP2B/UGT drug substrates needs further evaluation.
The British Herbal Pharmacopoeia (1990 ed.) recommends
a daily dose of 1.5e3.0 g dried rue [7]. In Taiwan, a female
patient with nonobstructive-type hypertrophic cardiomyo
pathy was taking bisoprolol, diltiazem, and amiloride/hydro-
chlorothiazide, the oxidation of which was influenced by
CYP2D6 and CYP3A4 [7]. After the patient took a daily dose of a
decoction prepared from 100 g of the aerial parts of rue (~1.7 g/
kg body weight) for 3 days, the symptoms of cardiotoxicity,
nephrotoxicity, hepatotoxicity, and coagulopathy were
observed. This patient apparently received a high daily dose
compared to the dose ranges described in the pharmacopeias
or on different websites. The toxicity event in Taiwan em-
phasizes the problem of overdosing with rue and the impor-
tance of the regulation ofmedicinal herbs. Using the Guidance
for Industry (specifically a section on estimating the
maximum safe starting dose in initial clinical trials for ther-
apeutics in adult healthy volunteers) issued by the Center for
Drug Evaluation and Research, a division of the United States
Department of Health and Human Services Food and Drug
Administration, the human equivalent dose for mice was
calculated using a standardized factor of 12.3 based on the
human to mouse surface area ratio. Watanabe et al [33] re-
ported that the estimate of human equivalent dose is equiv-
alent to the animal dose (g/kg) (Wanimal/Whuman)
1eb, in which aTable 2e Summary of effects of the components present in R. gr
and NQO activities in male mice.a
Treatment Cyp1a Cyp2a
Rue aqueous extract þ 
Rutin þ 
Fmix  
Rutin þ Fmix þ 
Fmix ¼ mixture of furanocoumarins; NQO ¼ NAD(P)H-quinone oxid
e ¼ unchanged by treatments.
a Micewere treatedwith 0.5 g/kg rue extract for 7 days. Rutin and themixt
to their respective amount in the mouse dose of rue extract. Cyp1a activ
mined. Coumarin and 7-pentoxyresorufin were used as substrates for
determined using p-nitrophenol and menadione as substrates, respectivvalue of b of 0.75 or 0.67 was considered for use. Since the
aqueous extract yield was 20.54 g aqueous extract/kg aerial
part of rue, the administration of 3 g rue to a 60 kg patient was
roughly estimated to be equivalent to 0.007e0.014 g rue
extract/kg in mice (20 g). Our results revealed that rue extract
at a dose lower than 0.1 g/kg did not alter Cyp1a, Cyp2b, and
UGT activities in mice. Cyp2d and Cyp3a activities were not
affected by rue extract at a dose of up to 0.5 g/kg. However,
species difference in the P450 induction is one of the key
factors of the difficulty of direct extrapolation from mouse
study to human response. To facilitate the assessment of rue-
mediated P450 induction in humans, the effects of rue extract
and its ingredients on human receptor activation and P450
expression shall be studied in cultured human hepatocytes.
Rutin and the rue furanocoumarins, chalepensin, 5-MOP,
8-MOP, and psoralen were identified in our preparation of rue
extract. A single intraperitoneal injection of 1 mg/kg 8-MOP
stimulated rat CYP1A and CYP2B activities after 24 hours [3].
Furthermore, rat CYP1A1/2 and UGT were induced by 8-MOP
at an oral dose of 150 mg/kg [34]. Our previous study demon-
strated that chalepensin (10mM) could activate mouse CAR in
HepG2 cells. Oral administration of chalepensin at 10 mg/kg
induced Cyp2b9/10 [4], whereas chalepensin did not affect
Cyp1a and UGT (unpublished results) activities in mice.
Considering the amounts of individual furanocoumarins in
rue extract, themouse dose of a single furanocoumarin seems
to be not enough to induce P450 or UGT. Our current studies
demonstrated that oral administration of Fmix (based on the
contents in the rue extract) to mice induced hepatic Cyp2b
activity. Rutin significantly induced hepatic Cyp1a activity.
The induction of Cyp1a and Cyp2b by themixture of rutin and
Fmix provided further evidence for the significant roles of rutin
and Fmix in the enzyme induction by rue extract (Table 2). The
ingredient(s) of rue, which stimulates microsomal UGT ac-
tivity in males, remains unclear.
In summary, our findings first demonstrate that the
repeated administration of rue extract induces hepatic Cyp1a
and Cyp2b activities in a dose-dependent manner in mice.
Compared with females, male mice were more responsive to
the rue-mediated induction of UGT. The elevation of P450 and
UGT activities was consistent with the elevation of protein
levels. Although the effects of the other types of rue in-
gredients cannot be excluded, rutin and Fmix contribute at
least in part to the P450 induction by rue.aveolens aqueous extract on hepatic cytochrome P450, UGT,
Cyp2b UGT NQO
þ þ 
e  
þ  
þ  
oreductase; UGT ¼ UDP-glucuronosyltransferase; þ ¼ induction;
ure of furanocoumarin were administered tomice in a dose according
ities toward 7-ethoxyresorufin and 7-methoxyresorufin were deter-
Cyp2a and Cyp2b, respectively. The UGT and NQO activities were
ely.
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